Sort
23,748 grants matching “melanoma”
CTLA4 as a guardian of the melanocyte stem cell immune privilege: Role in vitilligo
$209,220M. Raza Zaidi · Temple Univ Of The Commonwealth · R21 · FY2020 · AR
Immunopheonotyping of circulating tumor cells
$209,192Wafik S El-Deiry · Research Inst Of Fox Chase Can Ctr · R21 · FY2014 · CA
Community Outreach and Engagement (COE)
$209,162Jennifer Hatcher · University Of Arizona · P30 · FY2023 · CA
Community Outreach and Engagement (COE)
$209,162Monica Yellowhair · University Of Arizona · P30 · FY2024 · CA
DC Th Crosstalk in CTL Response to Mart 1
$209,160University Of Connecticut Sch Of Med/Dnt · R01 · FY2001 · CA
FUNCTION AND REGULATION OF CD/RAP
$209,127Barnes-Jewish Hospital · R01 · FY2000 · AR
Project 2 - Joshua Hood, PhD
$209,089Joshua L. Hood · University Of Louisville · P20 · FY2023 · GM
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis
$209,081Shiyong Wu · Ohio University Athens · R01 · FY2009 · CA
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis
$209,081Shiyong Wu · Ohio University Athens · R01 · FY2010 · CA
UV-induced and NOS-mediated Zn elevation, translation regulation and apoptosis
$209,081Shiyong Wu · Ohio University Athens · R01 · FY2008 · CA
Role of L1-CAM in Melanoma Progression and Agiogenesis
$209,074Anthony M Montgomery · University Of California, San Diego · R01 · FY2007 · CA
Molecular Predictive Testing in Ocular Melanoma
$208,936James W Harbour · Washington University · R01 · FY2008 · CA
Molecular Predictive Testing in Ocular Melanoma
$208,929James W Harbour · Washington University · R01 · FY2009 · CA
Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM
$208,881Timothy N Bullock · University Of Virginia · R21 · FY2020 · CA
Co-operative roles for YAP1 and UCHL5 in cancer progression and therapy
$208,800Kunal Rai · University Of Tx Md Anderson Can Ctr · R21 · FY2018 · CA
A-to-I microRNA Editing and Melanoma Metastasis
$208,800Menashe Bareli · University Of Tx Md Anderson Can Ctr · R21 · FY2018 · CA
Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma
$208,800Arupa Ganguly · University Of Pennsylvania · R21 · FY2015 · CA
Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy
$208,800Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · R21 · FY2017 · CA
Collateral Deletions Expose Targetable Metabolic Vulnerabilities in the PTEN locus
$208,800Florian Muller · University Of Tx Md Anderson Can Ctr · R21 · FY2018 · CA
Dana-Farber/Harvard Cancer Center
$208,750Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2024 · CA
Dana-Farber/Harvard Cancer Center
$208,750Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2025 · CA
A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
$208,738Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R21 · FY2024 · CA
Higher-order chromatin remodeling and regulation of pigmentation
$208,718Andrey Sharov · Boston University Medical Campus · R21 · FY2013 · AR
Define the role of POT1 mutations in genome instability and cancer
$208,643Agnel Sfeir · New York University School Of Medicine · U01 · FY2020 · CA
Radiometry Controlled Conformal Array Heat Applicator
$208,614University Of California San Francisco · R01 · FY2005 · CA